Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia
作者
Daniel A. Pollyea,Tessa Kerre,Dries Deeren,Y Beguin,Tara L. Lin,David A. Sallman,Sébastien Anguille,William Blum,Anne Flament,Eytan Breman,Caroline Lonez